HCV Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about HCV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Appalachian Partnership to Reduce Disparities (Aim 2)

HCVHIV/AIDSSTI
Wake Forest University Health Sciences141 enrolled1 locationNCT04378439
Recruiting
Not Applicable

California MEPS Hub

Substance Use Disorder (SUD)HIV PreventionHepatitis C Virus (HCV)+3 more
University of California, Los Angeles318 enrolled3 locationsNCT07433985
Recruiting
Phase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

Implementation ScienceIncarcerationInjection Drug Use+1 more
Lifespan40 enrolled1 locationNCT06953479
Recruiting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Hepatocellular CarcinomaHIV InfectionsCirrhosis, Liver+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07429864
Recruiting
Not Applicable

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

HCV
Johns Hopkins University120 enrolled9 locationsNCT05653232
Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

HIVHBVHCV+3 more
MagIA Diagnostics2,950 enrolled2 locationsNCT07170748
Recruiting
Not Applicable

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

Combined Point of Care Diagnostic of HIV, HBV and HCV
MagIA Diagnostics252 enrolled2 locationsNCT06082336
Recruiting
Not Applicable

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

HIVHepatitis C Virus (HCV)
McGill University Health Centre/Research Institute of the McGill University Health Centre548 enrolled9 locationsNCT07122219
Recruiting

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

HCVHEPATITIS C VIRUS CHRONIC INFECTION
McGill University300 enrolled12 locationsNCT07095192
Recruiting
Not Applicable

Persuasive Health Communication Intervention for HIV/HCV

Human Immunodeficiency Virus (HIV)Hepatitis C (HCV)
Icahn School of Medicine at Mount Sinai2,000 enrolled1 locationNCT05968573
Recruiting
Not Applicable

A Setting Focus Overdose Prevention Intervention

HIV InfectionsHCVDrug Overdose
Johns Hopkins Bloomberg School of Public Health285 enrolled1 locationNCT05320835
Recruiting

Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

HCV Infection
University of Seville728 enrolled4 locationsNCT06928259
Recruiting
Not Applicable

Tools to Identify People At Risk or Already Infected with HIV and HCV

HCVHIV/AIDSSTD
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal240,000 enrolled1 locationNCT06528626
Recruiting

The South-East Asian Transgender Health Cohort

HIVHCVSTIs
Institute of HIV Research and Innovation Foundation, Thailand450 enrolled5 locationsNCT05454579
Recruiting

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

Cirrhosis, LiverHCCHBV+2 more
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis60 enrolled1 locationNCT05781568
Recruiting
Not Applicable

National Prisons Hepatitis Education Project: Research Evaluation

HCV
Kirby Institute3,000 enrolled2 locationsNCT05942937